Announcements

4 March 2026
MDPI’s 2025 Best Paper Awards—Award-Winning Papers Announced


MDPI is honored to announce the recipients of the 2025 Best Paper Awards, celebrating exceptional research for its scientific merit and broad impact. After a rigorous evaluation process conducted by Academic Editors, this year’s awards showcase papers that stand out for their innovation, relevance, and high-quality presentation.

Out of a highly competitive pool, 396 winning papers have been recognized for their exceptional contributions. We congratulate these authors for pushing the boundaries of their respective disciplines.

At MDPI, we are dedicated to broadening the reach of innovative science. To learn more about the award-winning papers and explore research projects in your field of study, please visit the following links:

About MDPI Awards:

To reward the global research community and enhance academic dialogue, MDPI journals regularly host award programs across diverse scientific disciplines. These awards, serving as a source of inspiration and recognition, help raise the influence of talented individuals who have been credited with outstanding achievements and whose work drives the advancement of their fields.

Explore the Best Paper Awards open for participation, please click here.

 

24 April 2026
Prof. Dr. William Gerwick Appointed Chair of the 2026 Tu Youyou Award Committee

We are honored to announce that Prof. Dr. William Gerwick will serve as the Chair of the 2026 Tu Youyou Award Committee.

A world-renowned authority in marine natural products chemistry and pharmacology, Professor Gerwick is a Distinguished Professor at both the Scripps Institution of Oceanography and the Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California San Diego (UCSD). His pioneering work at the intersection of ocean sciences and drug discovery makes him a fitting leader for an award centered on transformative medicinal breakthroughs.

Under Professor Gerwick’s stewardship, the 2026 Tu Youyou Award Committee will focus on recognizing innovative and impactful research in natural products chemistry and medicinal chemistry, particularly work with the potential to drive meaningful advances in both scientific understanding and human health.

To provide further insight into his perspectives, we include below an interview with Professor Gerwick, in which he reflects on his scientific journey, his views on the field, and his vision for the Tu Youyou Award.

A Conversation with the Chair


1. Could you please introduce yourself and your research journey?

My research focuses on the natural products of marine algae and cyanobacteria, their application in medicine, their biosynthesis using genomic approaches, and innovative methods in the structure elucidation of natural products.

I received my BS degree from the University of California at Davis, my PhD from the University of California at San Diego, and conducted postdoctoral work at the University of Connecticut. After a couple of years in a junior faculty position at the Department of Chemistry at the University of Puerto Rico, I spent 21 years as Professor of Pharmacy at Oregon State University. In 2005, I returned to my PhD institution at the Scripps Institution of Oceanography and the Skaggs School of Pharmacy and Pharmaceutical Sciences at UC San Diego, where I am currently a Distinguished Professor of Oceanography and Pharmaceutical Sciences.

Throughout my career, I have been dedicated to advancing the field through both leadership and mentorship. I have served as president of the American Society of Pharmacognosy, chaired and co-chaired several major research conferences, and served as an associate editor for the Journal of Natural Products. I am a Fellow of the American Association for the Advancement of Science (AAAS) and of the American Society of Pharmacognosy. I have trained over 100 doctoral and postdoctoral students, and my research group has published nearly 500 papers and more than 25 patents on topics in the natural product sciences and medicinal chemistry.

2. What motivated you to accept the role of Chair of the 2026 Tu Youyou Award Committee?

Of course, I am a huge supporter of all awards that are given in recognition of excellent scientific research, and especially so in the natural products sciences and medicinal chemistry. However, this award is truly special in that it recognizes scientific excellence as well as impact, and is given in the name of an individual, Tu Youyou, who clearly had many challenges along the path to reach the pinnacle of her success. Not only was she the first Chinese person to win a Nobel prize in this area, but she was also the first Chinese woman to receive a Nobel prize, and this was achieved without graduate education in China or elsewhere. It’s a true testament to what can be achieved by hard work, determination, and vision. To read the history of her extraordinary approach to discovering novel antimalarial compounds from Traditional Chinese Medicine is truly inspirational. It is, therefore, the inspiration provided by the extraordinary life and career of Tu Youyou that motivated me to accept the Chair of the Award Committee for 2026.

3. How do you view the role of natural products chemistry and medicinal chemistry in today’s scientific landscape, and what major advances over the past decade have shaped this field?

A quite remarkable integration of fields is currently transforming natural products science and medicinal chemistry. In natural products, we are seeing integration of different omics methods, from metabolites to proteins to nucleic acids. Sophisticated biological and pharmacological approaches are driving the discovery of exquisitely potent and selective natural products. Advances are being made to integrate molecular-level recognition of natural products with chemical ecological studies, and sophisticated methods of structure determination using Artificial Intelligence or pioneering new tools such as microED are being applied with increasing frequency. High-level synthetic methodologies, such as protecting group-free synthetic routes, are enhancing medicinal chemistry, accelerating the identification of lead molecules with attractive pharmaceutical properties at an increasing pace.

4. How do you consider the balance between fundamental discovery (e.g., new molecules or mechanisms) and practical impact (e.g., therapeutic applications)?

Many individuals are excellent scientists and mentors, and have essential roles in developing our culture that values science and the scientific method. It should also be pointed out that not all scientific discoveries are going to have a broad societal impact, but they are nevertheless critical to the overall body and structure of science. But it is a truly remarkable individual who makes a key scientific discovery, recognizes its potential value to society in general, and then has the skills and determination to bring it forward as a useful product. That was the type of person the Tu Youyou is, and that is the type of person who is honored by the prize in her name.

5. What do you see as the key challenges or opportunities currently facing the field?

We are on the crux of an amazing revolution in many of the sciences, including natural products and medicinal chemistry; the purposeful application of Artificial Intelligence to solving many of the difficulties involved in the search for new pharmaceuticals from Nature. AI is transforming how we select organisms for study, what pharmaceutical targets to go after, rapidly resolving the chemical structures of new compounds, identifying efficient routes to their chemical synthesis, understanding their molecular mechanisms of action, and finally, designing their clinical application. The role of people in these pursuits is changing. Increasingly, the human role will be providing overall vision: what can we do? What should we do? And it is important to remember that AI is providing hypotheses, not truth. Scientists with expert domain knowledge will be critical for discerning the correctness of hypotheses put forth by AI. Altogether, advances in technology, expanding knowledge, and the appropriate use of AI methods are preparing society to be able to address emerging diseases, such as pandemics, as well as conditions that are not effectively treated by currently existing therapeutics.

6. How do you expect the Tu Youyou Award to contribute to the advancement of natural product chemistry, medicinal chemistry, and human health over the coming years?

The Tu Youyou Award is potentially transformative for the broad fields of natural products science and medicinal chemistry as it brings a significantly increased level of visibility to these topics and their contributions to human health. It will be crucial to have excellent communication to news agencies, social media and other communication outlets so that the general public is informed and educated on the high impact of these natural product/medicinal chemistry contributions. This will bring increased funding, attract promising students, and generally enrich the interface of these fields with the health sector.

7. What message would you like to convey to the research community and the public during this open nomination phase?

This prize gives broad societal visibility to the role that natural products have had in shaping a majority of our current medicines, as well as understanding the life forms with whom we share the planet. Further, it recognizes a woman scientist working under sub-optimal conditions who could persevere and make discoveries of global impact. The prize and what it represents, therefore, inspires current and future generations to engage in the study of Nature and its relationship to Human Health, to overcome adversity, and to aspire to making one’s life impactful.

About the Tu Youyou Award

Established in 2016, the Tu Youyou Award seeks to honor those who excel in the fields of natural products chemistry and medicinal chemistry. This award offers a total prize of CHF 100,000, which will be equally divided among the winners if there is more than one, with each recipient receiving an award medal and a certificate.

The 2026 Tu Youyou Award is open for nominations until 31 October 2026. We encourage all eligible candidates to participate in this prestigious recognition, as this award not only honors individual achievement but also encourages further scientific exchange, exploration and discovery in critical areas of medicine.

If you are interested in participating, please visit the Tu Youyou Award website for more information on the nomination requirements.

 

20 April 2026
Meet Us at the 2026 China Biomedical Engineering Conference & Medical Innovation Summit (BME), 29–31 May 2026, Suzhou, China


Conference:
2026 China Biomedical Engineering Conference & Medical Innovation Summit (BME)
Date: 29–31 May 2026
Location: Suzhou, China

MDPI will be attending the 2026 China Biomedical Engineering Conference & Medical Innovation Summit (BME) as an exhibitor. This meeting will be held in Suzhou, China from 29 to 31 May 2026.

The conference, hosted by the Chinese Society for Biomedical Engineering, will be held in Suzhou from May 29 to 31, 2026. Adhering to the theme of “Integrated Development of Medicine and Engineering, Innovation Leading the Future”, the conference focuses on key areas and technologies in biomedical engineering, with the mission of promoting the self-reliance and strength of domestically produced medical devices. It highlights the core value of medical engineering integration for health maintenance and treatment advancements, and facilitates the deep integration of disciplines and industries.

The following open access journals will be represented:

If you are attending this conference, please feel free to start an online conversation with us. Our delegates look forward to meeting you in person at booth #9 and answering any questions that you may have. For more information about the conference, please visit the following website: https://bme2026.sciconf.cn/.

16 April 2026
MDPI’s Newly Launched Journals in the First Quarter of 2026


Our portfolio of journals available for publishing up-to-date research in immediate open access format has been further expanded. In the first quarter of 2026, nine new journals released their inaugural issues and three transferred journals released their first issue as part of MDPI, covering the subjects of clinical medicine, chemistry, computer science & mathematics, engineering, environment & ecology, and social sciences & psychology.

We extend our gratitude to the Editors-in-Chief, Associate Editors, and Editorial Board Members who will shape the future course of these brand-new journals. Each journal is dedicated to upholding strong editorial standards through a thorough peer review process, ensuring impactful open access scholarship.

Please feel free to browse and discover more about the new journals below.

New Journals

Founding Editor(s)-in-Chief

Journal Topics (Selected)

Prof. Dr. Matt Oehlschlaeger,
Rensselaer Polytechnic Institute, USA
Editorial | view inaugural issue

AI-based chemical data analysis, prediction, and discovery; AI-enabled chemical reaction prediction, synthesis planning, and retrosynthesis; AI in bioorganic chemistry and chemical biology; digital twins and simulation of chemical processes; AI-powered chemical education and pedagogy |
view journal scope | submit an article

Prof. Dr. Guang Jia,
Peking University, China
Editorial | view inaugural issue

occupational hazards and exposure science; occupational health effects and susceptibility; occupational risk assessment and management; occupational health intervention, promotion, and policy |
view journal scope | submit an article

Prof. Dr. Alessandro Miani,
Italian Society of Environmental Medicine (SIMA), Italy
University of Milan, Italy
Prof. Dr. Jing Shang,
Peking University, China
Editorial | view inaugural issue

environmental exposures and health; the built environment and public health; One Health approach; environmental justice and health equity; environmental policies and interventions |
view journal scope | submit an article

Prof. Dr. Miriam H. A. Bopp,
Marburg University, Germany
Center for Mind, Brain and Behavior (CMBB), Germany
Prof. Dr. Christopher Nimsky,
Marburg University, Germany
Center for Mind, Brain and Behavior (CMBB), Germany
Editorial | view inaugural issue

neuroimaging technology and tool; multimodal neuroimaging integration and analysis;
dynamic modeling of brain networks; neuroimaging big data and cloud computing; translational and preclinical neuroimaging |
view journal scope | submit an article

Prof. Dr. Raul A. Urrutia,
Medical College of Wisconsin, Milwaukee, USA
Editorial | view inaugural issue

personalized translational and clinical oncology research that contribute to a deeper understanding of cancer diagnoses, prognoses, prevention, and treatment specifically for individual patients |
view journal scope | submit an article

Prof. Dr. Pierre Boulanger,
University of Alberta, Canada
Editorial | view inaugural issue

AI in disease detection, diagnosis, prediction, and treatment; medical informatics; AI in genomics and precision medicine; AI in drug discovery and development;
AI in healthcare; intelligent devices and instruments |
view journal scope | submit an article

Prof. Dr. Zhaokui Wang,
Tsinghua University, China
Editorial | view inaugural issue

astrodynamics; spacecraft technology; satellite technology; space transportation; space vehicle design, propulsion, and avionics; space energy, power and propulsion |
view journal scope | submit an article

Prof. Dr. Richard J Hauer,
University of Wisconsin–Stevens Point, USA
Editorial | view inaugural issue

park design, planning, and evaluation; park and art; park, industrialization, urbanization, and civilization; park and education; park and smart society; park role in SDGs;

park services for humans |
view journal scope | submit an article

Prof. Dr. Stacey L. Connaughton,
Purdue University, USA
Editorial | view inaugural issue

conflict resolution; peacebuilding; peacemaking; mediation, reconciliation, and transitional justice; sustaining peace |
view journal scope | submit an article

Transferred Journals

Editor(s)-in-Chief

Journal Topics (Selected)

Prof. Dr. Gianluigi Vendemiale,
University of Foggia, Italy
Editorial | view first issue

physiology and pathology of aging; biogerontology; epidemiology; clinical geriatrics; pharmacology; geriatric nursing |
view journal scope | submit an article

Prof. Dr. Michele Maffia,
University of Salento, Italy
Prof. Dr. Prisco Piscitelli,
Italian Society of Environmental Medicine, Italy
Editorial | view first issue

cellular and developmental biology; physiology, pathophysiology and endocrinology; diagnostic tools, therapies and public health |
view journal scope | submit an article

Dr. Warren S. Joseph,
American Podiatric Medical Association, USA
Editorial | view first issue

foot and ankle medicine; podiatric medicine |
view journal scope | submit an article

We would like to thank everyone who has supported the development of open access publishing. If you would like to create a new journal, you are welcome to send an application here or contact the New Journal Committee (newjournal-committee@mdpi.com).

2 April 2026
2026 Tu Youyou Award—Open for Nominations


We are delighted to announce that nominations are now open for the 2026 Tu Youyou Award. Named after Nobel Laureate Tu Youyou, whose discovery of artemisinin has saved millions of lives, this award recognizes researchers whose work advances the fields of natural products chemistry and medicinal chemistry, while also contributing to human health.

Prize

– CHF 100,000;
– A medal;
– A certificate.

The monetary prize will be shared equally should there be multiple recipients.

Who May Be Nominated?

– Scientists with outstanding achievements and contributions in the fields of natural products chemistry and medicinal chemistry.

Nominees must be individuals; team or group nominations are not permitted. Nominations are valid only for the current award cycle.

Who May Submit a Nomination?

– The director of the nominee’s host research institution or recognized scientists within the field.

Self-nominations will not be considered.

Nomination Materials

– A biographical sketch;
– A detailed description of the nominee’s contributions;
– 5–10 representative academic publications;
– A list of academic honors, awards, and funded projects;
– A nomination letter signed by two nominators.

How to Submit?

Submit nominations online via the following link: https://tuyouyouprize.org/nomination

Important Dates

– Nomination Deadline: 31 October 2026
– Winner Announcement: March 2027

For further information, please visit the Tu Youyou Award website (https://tuyouyouprize.org/). For any inquiries, please contact the Tu Youyou Award Team at tuyouyouaward@mdpi.com.

1 April 2026
Meet Us at the 9th China–Europe Symposium on Biomaterials in Regenerative Medicine in 2026, 10–13 May 2026, Beijing, China


Conference: The 9th China–Europe Symposium on Biomaterials in Regenerative Medicine
Organization: Chinese Society for Biomaterials
Date: 10–13 May 2026
Location: Beijing, China

The China–Europe Symposium on Biomaterials in Regenerative Medicine (CESB) is a premier international conference jointly organized by the Chinese Society for Biomaterials (CSBM) and the European Society for Biomaterials (ESB). Initiated in 2006 by Prof. Xingdong Zhang (then President of the Chinese Committee for Biomaterials, the predecessor to the CSBM) and Prof. Luigi Ambrosio (then President of the ESB), CESB has been held biennially, alternating between China and Europe, to foster cross-continental collaboration and knowledge exchange in the field of biomaterials and regenerative medicine.

CESB brings together leading researchers, clinicians, and industry experts from China and Europe to discuss cutting-edge advancements, innovative technologies, and clinical applications in biomaterials. The symposium covers a wide range of topics, including tissue engineering, nanotechnology, immunomodulation, advanced biomaterials, and translational medicine.

As a key platform for sustained Sino-European scientific collaboration, CESB continues to drive global progress in biomaterials research and its clinical implementation, contributing to the future of regenerative medicine worldwide.

The following open access journals will be represented:

If you plan on attending this conference, please feel free to stop by our booth. Our delegates look forward to meeting you in person.

For more information about the conference, please visit the following link: https://cesb2026.csbm.org.cn/index.php/index/index/index.html.

31 March 2026
MDPI INSIGHTS: The CEO’s Letter #33 - 2025 Annual Report, Preprints.org, IWD, Recapping Viruses 2026 & Romania Salon

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Scaling Open Access with Integrity: MDPI Annual Report 2025

I am pleased to share the release of MDPI’s 2025 Annual Report, reflecting our continued progress as one of the world’s leading open access publishers. The report highlights not only our growth, but also the continued evolution of our publishing model and our commitment to quality, transparency, and collaboration.

You can explore the full report here: https://mdpi-res.com/data/mdpi_annual_report_2025_0401.pdf?1775045421

Or visit the interactive page: https://www.mdpi.com/annual-report-2025/

A Year of Growth and Responsibility

2025 was a year of significant growth for MDPI. We received over 669,000 manuscript submissions, the highest in our history, while maintaining a rejection rate above 60%, reinforcing our commitment to both scale and quality.

We published 261,576 peer-reviewed open access articles across a portfolio of 500 journals, supported by a global community of more than 68,000 Editorial Board Members and 209,000 reviewers.

Scaling with Integrity

Growth alone is not the objective; how we grow matters.

Our 2025 Annual Report, Scaling Open Access with Integrity, reflects our continued focus on building the systems and processes that support reliable and trustworthy publishing. As submission volumes increase globally, so too does the importance of robust editorial workflows, research integrity frameworks, and the infrastructure required to support them.

In 2025, we continued to invest in:

  • Research integrity and quality assurance processes
  • Editorial support and reviewer engagement
  • Transparency across the publishing workflow

These efforts ensure that scale does not come at the expense of rigor, but rather reinforces it.

Validation Through Indexing and Visibility

As MDPI continues to grow, validation of quality remains essential.

In 2025, the number of MDPI journals indexed in the Web of Science Core Collection increased from 298 to 329, while Scopus coverage reached 355 journals, including 45 new acceptances. Coverage in major biomedical databases (PMC/Medline/PubMed) expanded to 95 journals, and indexing in Ei Compendex increased significantly.

These milestones reflect the strength of our editorial processes and the trust placed in our journals by independent indexing bodies.

Importantly:

  • 96% of all MDPI articles are indexed in Web of Science databases
  • More than 1.75 million articles are indexed, with an average of 13 citations per article

Recognition through Journal Citation Reports also continues to grow:

  • 298 journals received Impact Factors
  • 65% ranked in the top half of their categories
  • 61 journals achieved top-quartile positions

These developments demonstrate that growth and quality are advancing together, supported by strong editorial oversight and consistent performance across our journal portfolio.

Strengthening Partnerships and Community

Open access is a collaborative endeavor.

In 2025, we expanded our institutional partnerships to more than 1,000 IOAP agreements, helping simplify publishing for researchers and institutions worldwide.

We also hosted 60 in-person conferences and virtual events, bringing together more than 28,000 participants to exchange ideas, share research, and strengthen connections across the global scientific community.

At the heart of everything we do is this community of authors, editors, reviewers, and partners who make open science possible.

Looking Ahead

Open access continues to move toward becoming the standard model for sharing research globally. With that growth comes increased responsibility.

Our focus moving forward is to continue building a publishing ecosystem that is:

  • Collaborative, to serve the research community
  • Rigorous, to ensure quality
  • Transparent, to support trust
  • Scalable, to meet global demand

We believe that open access, when combined with strong editorial standards and integrity, is the most effective way to accelerate scientific progress.

Thank you to all the scholarly community who collaborated with us and our MDPI staff for your continued dedication and contributions in making 2025 a successful year.

Impactful Research

Celebrating Ten Years of Preprints.org: Accelerating Open Research

In 2026, MDPI’s preprints server Preprints.org marked its 10th anniversary as a platform dedicated to accelerating the dissemination of research. Since its launch, Preprints.org has grown into a global platform that hosts more than 120,000 preprints contributed by hundreds of thousands of researchers worldwide, generating tens of millions of views and downloads and demonstrating the value of sharing research openly and rapidly.

At MDPI, we are proud to celebrate ten years of Preprints.org supporting the mission of open science. Over the past decade, we have seen how early sharing of research can accelerate collaboration and help ideas move more quickly from discovery to impact.

The Evolution of Preprints

While Preprints.org launched in 2016, the idea behind it has deeper roots. The concept of rapid research dissemination has existed for decades, with early preprint servers showing how open sharing can accelerate scientific progress.

Over the past decade, preprints have become an increasingly important part of scholarly communication. Researchers across disciplines are looking at faster ways to share their discoveries, exchange ideas, and receive feedback from the global scientific community.

Preprints in a Growing Research Ecosystem

The global preprint landscape has expanded significantly over the past decade, with multiple platforms serving different research communities. The figure below (sourced from James Butcher newsletter), based on data from Dimensions (Digital Science), shows the growth of preprint outputs across several major platforms over time.

Among these platforms, arXiv (the pioneering preprint server) has experienced great growth in recent years. At the same time, other platforms have continued to expand their reach across disciplines, capturing increasing global interest in early research sharing.

Preprints.org contributes to this evolving ecosystem by providing a multidisciplinary platform that works in synergy with academic journals, helping researchers bridge the gap between rapid dissemination and the formal publication process.

Celebrating the First Decade

To commemorate this milestone, Preprints.org launched a 10th Anniversary celebration hub highlighting the impact of preprints and the researchers who contribute to them.

One of the central initiatives is the Popular Preprints of the Decade Award, recognizing influential preprints published between 2016 and 2026 across multiple research fields. Through community voting, the award will recognize research that has generated high engagement and visibility within the global research community.

Looking Ahead: The Next Decade of Preprints

As research communication continues to evolve, preprints will continue to play an important role in enabling faster collaboration, improving transparency, and expanding access to knowledge. The next decade may bring further integration between preprint platforms and journals, new tools for discovery and evaluation, and greater global participation in open science.

At MDPI, we remain committed to supporting researchers through platforms that encourage the open exchange of ideas. The success of Preprints.org over the past ten years reflects the engagement and trust of the global research community – authors, readers, reviewers, and collaborators who believe in the value of sharing knowledge openly.

Congratulations to everyone involved in the development and growth of Preprints.org over the past decade!

Inside MDPI

Beyond International Women’s Day: Supporting Women in Research

International Women’s Day (IWD) offers an opportunity to recognize the achievements of women around the world and reflect on how we can continue building a more inclusive future. In research and academia, this conversation carries particular importance, as scientific progress depends on diverse perspectives, and supporting women in science is essential to strengthening the global research ecosystem.

For MDPI, IWD is an opportunity to celebrate the achievements of women in research and highlight the initiatives, conversations, and collaborations that help support researchers across disciplines and career stages.

Highlighting Women in Science Across MDPI

This year, MDPI marked International Women’s Day with a global campaign highlighting research, awards, and perspectives that support women in science. Throughout the week, our teams shared content across MDPI’s social media channels sharing the work of women researchers and encouraging engagement across the academic community.

As part of this initiative, MDPI published several blog articles exploring important themes related to gender equity in research. One article, Give Support, Gain Progress: Retaining Women in Science, discusses the importance of mentorship, institutional support, and inclusive research environments in helping women build sustainable scientific careers.

Another featured article, Bridging the Gap in Women’s Health Research, highlights the ongoing need to address disparities in health research and ensure that women’s health receives the scientific attention and investment it deserves.

These topics capture the notion that supporting women in science benefits not only individual researchers but the entire scientific community. When researchers from diverse backgrounds can contribute their perspectives and ideas, the scope and impact of scientific discovery expand.

Creating Spaces for Dialogue

Beyond online content, MDPI is also supporting conversations about women in research through community engagement.

On 10 March, MDPI UK hosted the “Women in Research” event, bringing together researchers and professionals to share experiences and discuss the opportunities and challenges women face throughout their scientific careers. Events like these are an opportunity for open dialogue, mentorship, and networking to create more inclusive research communities.

Looking Beyond a Single Day

While IWD is an important moment of recognition, progress requires ongoing effort.

Supporting women in research involves many forms of engagement: from mentorship and collaboration to creating inclusive environments in which diverse voices are heard and valued. Publishers, institutions, and researchers all play a role in building this ecosystem.

At MDPI, we remain committed to supporting the global research community and to promoting open access publishing as a foundation for accessible and inclusive knowledge-sharing.

As we reflect on IWD this year, we recognize the many women who contribute to research as authors, reviewers, editors, mentors, and educators; we also recognize the impact they continue to have on the advancement of science. The influence of women in research extends far beyond a single day of recognition, reminding us that supporting them is a commitment that continues throughout the year.

Coming Together for Science

Highlights from Viruses 2026 – New Horizons in Virology (11–13 March)

Through 11–13 March, we successfully delivered the Viruses 2026 – New Horizons in Virology MDPI conference in Barcelona, bringing together an international community of researchers, editors, and partners dedicated to advancing the field of virology.

Conference Highlights

Viruses 2026 in numbers:

  • 198 total registrations, with 171 attendees on site
  • 233 submissions, with 122 accepted
  • 42 short talks, 9 flash talks, and 80 posters
  • 13 invited speakers and 1 keynote speaker

The strong level of participation and quality of submissions once again demonstrate the relevance of the Viruses community.

A standout moment was the keynote lecture by Dr. Ho, which also attracted an NBC documentary film crew, highlighting the broader impact of the research being presented.

Scientific Programme

The conference programme covered areas across modern virology, including viral replication, pathogenesis, immunology, and public health. Sessions explored topics on antiviral therapeutics and vaccines, innate immunity, virus–host interactions, and the structure and mechanisms of virus replication.

Together, these discussions highlighted both the fundamental biology of viruses and the translational challenges of addressing emerging infectious diseases, reflecting the breadth and continued importance of virology research in a global context. The programme also included a sponsored workshop on research data management in virology, further emphasizing the importance of data practices in advancing the field.

Thank You

Feedback from participants has been very positive, and I would like to thank the Conference team for the organization and delivery of this year’s event.

Thank you to our Viruses journal team and all colleagues involved behind the scenes in supporting the delivery of the event. As noted by Dr. Eric Freed (EiC of Viruses), the success of this edition gives us strong momentum as we look ahead to the next conference in 2028, with opportunities to further expand participation and engagement.

Closing Thoughts

Recap from MDPI Romania Salon in Cluj-Napoca (24 March)

On 24 March, we had the opportunity to meet with members of the Romanian research community in Cluj-Napoca at our MDPI Romania Salon. The event was a space for presentations, open discussion, and the exchange of perspectives on publishing and the research landscape in Romania.

We welcomed 39 participants, including 27 researchers from institutions across Romania, representing cities such as Cluj-Napoca, Timișoara, and Reșița. Among them were Editorial Board Members, Associate Editors, and Guest Editors, all of whom play an important role in collaborating with MDPI and shaping the quality and direction of academic publishing.

A Shared Commitment to Research Excellence

These events reflect MDPI’s commitment to connecting with and supporting researchers by means of transparency, dialogue, and collaboration. During the day, MDPI colleagues shared a series of presentations covering different parts of our publishing ecosystem:

  • MDPI’s presence in Romania – Anamaria Vartolomei (Journal Relationship Specialist (JRS), Section Managing Editor (ME))
  • MDPI’s performance, growth, and impact in Romania – Stefan Tochev (CEO)
  • Academic services, initiatives, and projects supporting researchers – Ioana Preda (JRS, Section ME)
  • Best practices and standards in publication ethics – Lavinia Rogojina (Research Integrity Manager)
  • Panel session on ethics, AI, and peer review – Lavinia Rogojina, Ioana Preda, Doris Larisa Albu (JRS, Section ME), Cristina Georgiana Spelmezan (JRS, Section ME)
  • Closing remarks – Lavinia Dumitrela Cozma (Operations Manager, Section ME)

Feedback from participants was very positive, particularly regarding the quality of discussions, the relevance of the topics, and the opportunity to engage directly with MDPI colleagues. What stood out most was the openness of the discussion. These events are important not only for the purposes of presenting what we do, but also as an opportunity to listen, understand concerns, and continue to build alignment with the research community.

Romania and the Growth of Open Access Publishing

The Romanian research landscape continues to show growth in open access (OA) publishing.

In 2025:

  • 72% of all publications in Romania were published as OA
  • Of these, 74% were Gold Open Access

Over the past five years, Romania has produced more than 109,000 publications, with approximately 71% available openly, highlighting a sustained shift toward accessibility and knowledge-sharing.

Within this landscape, MDPI continues to play a significant role:

  • MDPI is the leading OA publisher in Romania, contributing 42% of all OA publications in 2025
  • More than 37,000 articles have been published with MDPI by Romanian institutions since 1996
  • This figure includes over 7,500 publications in 2025 alone
  • More than 400 Editorial Board Members from Romania collaborate with MDPI across disciplines

These trends show the growth of OA and the strength of collaboration between MDPI and the Romanian research community.

Looking Ahead

As academic publishing continues to evolve, maintaining open and transparent communication with researchers is essential. Events such as our Salons and Summits provide great opportunities to exchange perspectives and to build trust and collaboration.

Thank you to all participants who joined us in Cluj, and to our teams in Romania for delivering a successful event. A special thank-you to Alina-Florina Agafitei (Marketing Specialist) for her care and attention to detail in delivering the Salon.

Stefan Tochev
Chief Executive Officer
MDPI AG

25 March 2026
Acknowledging the Contributions of Our Reviewers in 2025


As a pioneer in open access publishing, MDPI maintains rigorous publication standards. This mission relies on the dedication and expertise of our reviewers, who invest their time and knowledge to ensure the quality and integrity of the research we publish.

In 2025, over 209,000 reviewers contributed to the peer-review process at MDPI, providing more than 1.3 million review reports for our journals. To express our gratitude, MDPI’s Reviewer Recognition Program highlights reviewers across over 400 journals, featuring those who have assessed at least one manuscript and agreed to be acknowledged.

In addition, MDPI has identified its Top 1000 Reviewers of 2024 to recognize those whose expertise, dedication, and thoughtful evaluations were particularly outstanding.

Many journals have also established Outstanding Reviewer Awards to honor our reviewers’ commitment to publication excellence. Together with the Exceptional Reviewer List, we showcase the importance of reviewers’ work and their time and dedication.

These initiatives serve to express our deepest appreciation and gratitude towards the whole reviewer community. In recognition of their contributions, we also welcome new researchers to join this community. If you would like to contribute to open access publishing, learn more about the reviewers’ benefits and sign up to join us.

20 March 2026
Meet Us at the EUROPT(R)ODE XVII Conference, 29 March 2026–1 April 2026, Jena, Germany


MDPI will be attending the EUROPT(R)ODE XVII conference, which will be held from 29 March to 1 April 2026, in Jena, Germany.

EUROPT(R)ODE XVII will be hosted in Jena, Germany, the historic “City of Light”, and chaired by Professor Jürgen Popp, Scientific Director of the Leibniz Institute of Photonic Technology. This conference is a flagship international event dedicated to the advancement of chemical and biochemical optical sensing. It will gather leading scientists, engineers, and industry professionals to explore the latest innovations, foster interdisciplinary collaboration, and discuss the future direction of the field.

The four-day conference will feature six plenary lectures by world-renowned researchers such as Alexey Gorshkov (USA), Laura Na Liu (Germany), and Ralf Jungmann (Germany). These will be complemented by parallel sessions covering a wide spectrum of topics, from fundamental research in plasmonic, quantum-enhanced sensing and single-molecule detection to applied technologies in wearables, microfluidics and AI-driven data analytics. With over one hundred oral presentations and a dedicated poster session, the conference will showcase cutting-edge work from leading research groups across the globe.

The following MDPI journals will be represented:

If you plan to attend this conference, please feel free to stop by our booth and have a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following link: https://europtrode2026.org/.

28 February 2026
Meet Us at the TERMIS-EU 2026 Conference, 21–24 April 2026, Palma de Mallorca, Spain


Conference:
TERMIS-EU 2026 Conference
Date: 21–24 April 2026
Location: Palma de Mallorca, Spain

From 21 to 24 April 2026, in Palma de Mallorca, Spain, MDPI will be attending the TERMIS-EU 2026 Conference as an exhibitor, welcoming researchers from diverse backgrounds to visit and share their latest ideas.

Under the theme of “Accelerating multidisciplinary innovation to close the gap in clinical translation”, TERMIS-EU 2026 promises an enriching experience where leading academic and clinical researchers and industry experts will converge to share their expertise, explore emerging trends, and foster collaborations that will drive the field forward.

We look forward to welcoming you to Palma de Mallorca for an unforgettable experience at TERMIS-EU 2026!

The following MDPI journals will be represented:

If you are planning to attend this conference, please do not hesitate to start an online conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information, please visit https://eu2026.termis.org/.

Back to TopTop